Sunday, June 14, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 246 of 1,261

  1. US 11413337

    Peptide conjugated particles for the treatment of inflammation

    Northwestern University · Granted Aug 16, 2022 · Expires Aug 11, 2042

    granted

  2. US 11413301

    Composition comprising sea cucumber extract as effective ingredient for preventing and treating Bruch's membrane dysfunction-related disease

    Altregen Co., Ltd. · Granted Aug 16, 2022 · Expires Aug 11, 2042

    granted

  3. US 11413329

    Cancer cell trap

    The Board of Regents of the University of Texas System · Granted Aug 16, 2022 · Expires Aug 11, 2042

    granted

  4. US 11413309

    Compositions and methods for immune cell modulation in adoptive immunotherapies

    Fate Therapeutics, Inc. · Granted Aug 16, 2022 · Expires Aug 11, 2042

    granted

  5. US 11413350

    Long-acting polymeric delivery systems

    Heron Therapeutics, Inc. · Granted Aug 16, 2022 · Expires Aug 11, 2042

    granted

  6. US 11414416

    Compounds and uses thereof

    FOGHORN THERAPEUTICS INC. · Granted Aug 16, 2022 · Expires Aug 11, 2042

    granted

  7. US 11413420

    Nitric oxide delivery devices

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 16, 2022 · Expires Aug 11, 2042

    granted

  8. US 11413296

    Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract

    The Regents of the University of California · Granted Aug 16, 2022 · Expires Aug 11, 2042

    granted

  9. US 11406656

    Methods and compositions for administration of iron

    American Regent, Inc. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted

  10. US 11407998

    Twist signaling inhibitor compositions and methods of using the same

    The Regents of the University of California · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted

  11. US 11406618

    Polymer-des-ethyl sunitinib conjugates

    Nektar Therapeutics · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted

  12. US 11406716

    Modified RNAi agents

    Alnylam Pharmaceuticals, Inc. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted

  13. US 11407825

    NaPi2b-targeted polymer antibody-drug conjugates and methods of use thereof

    Mersana Therapeutics, Inc. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted

  14. US 11406646

    Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide

    United States Government as represented by the Department of Veterans Affairs · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted

  15. US 11407818

    Antibodies that bind to dengue virus serotype 4 (DENV4) and methods of making and using the same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted

  16. US 11407759

    Solid forms of 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione

    ACTUATE THERAPEUTICS INC. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted

  17. US 11407764

    AhR modulators

    IDEAYA Biosciences, Inc. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted

  18. US 11407752

    Substituted 4,6-dihydrospiro[[1,2,3]triazolo[4,5-b]pyridine-7,3′-indoline]-2′,5(3H)-dione analogues

    The Board of Regents of the University of Texas System · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted

  19. US 11407747

    Compositions and methods for inhibiting kinases

    Inhibikase Therapeutics, Inc. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted

  20. US 11407736

    RIP1 inhibitory compounds and methods for making and using the same

    Rigel Pharmaceuticals, Inc. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted

  21. US 11407813

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted

  22. US 11407822

    Treatment of fibrodysplasia ossificans progressiva

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted

  23. US 11407820

    Modulating the alternative complement pathway

    The Regents of the University of Colorado · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted

  24. US 11407800

    Translatable molecules and synthesis thereof

    ARCTURUS THERAPEUTICS, INC. · Granted Aug 9, 2022 · Expires Aug 4, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.